Policy / Pricing Italy leads the way on child genetic disease diagnosis PharmaphorumA scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems.Policy / PricingRare DiseaseRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) Pharmaphorum A scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems. Policy / PricingRare DiseaseRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Asahi Kasei acquires German company AicurisNext: Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
